#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma Hypoparathyroidism Vulval cancer recurrent Glycogen storage disease type I Chronic graft versus host disease in skin Henoch-Schonlein purpura nephritis Brain injury Ewing's sarcoma metastatic Thermal burn Hereditary ataxia Liver abscess Thalassaemia alpha Myxoid liposarcoma Hypersensitivity pneumonitis Cervix carcinoma recurrent More trials…

    Learn about Rare Diseases

    Fabry’s disease – Diagnostics Cytokine release syndrome – Diagnostics Adrenocortical carcinoma – Treatment Indolent systemic mastocytosis – Diagnostics Breast angiosarcoma – Life with Disease Breast angiosarcoma Synovial sarcoma – Trials in Disease Short-bowel syndrome – Treatment Pleomorphic leiomyosarcoma Prader-Willi syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azelastine Hydrochloride TIL CELLS Mebendazole Itolizumab OBI-821 LY3537021 Dapagliflozin Betamethasone Dipropionate Bms-986315 Glycopyrronium Bromide GSKVX000000034795 Methadone Hydrochloride VX-407 Azathioprine Camphor Epacadostat Posdinemab Baclofen ACICLOVIR SODIUM Tofacitinib More therapies…

    Learn about Your Condition

    Mantle cell lymphoma recurrent Haemolytic uraemic syndrome Micrographic skin surgery Malignant melanoma stage III Hypoalbuminaemia H1N1 influenza Large cell lung cancer Pleural mesothelioma Labour pain Rectal cancer stage II Cholangitis sclerosing Tuberous sclerosis complex Post procedural oedema Colorectal cancer stage IV Respiratory failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Ivosidenib
    Germany

  • Study on the Safety of Eganelisib Alone and with Cytarabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndromes

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia recurrent
    • Acute myeloid leukaemia refractory
    Investigated Drugs:
    • EGANELISIB
    • Cytarabine
    Spain

  • Long-term Follow-up Study for Patients with Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma Treated with OC-1 Cells

    Recruiting

    3 1 1
    Investigated Drugs:
    • Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
    Spain

  • Study on Vedolizumab and Ustekinumab for Patients with Crohn’s Disease and Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    • Ustekinumab
    Denmark

  • Study on Dapagliflozin, Finerenone, and Semaglutide for Treating Chronic Kidney Disease in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    • Semaglutide
    Denmark Germany Italy Spain Sweden

  • Study on Preoperative Antibiotics for Patients with Acute Cholecystitis: Comparing Ertapenem, Ciprofloxacin, and Cefuroxime

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholecystitis acute
    Investigated Drugs:
    • Ertapenem
    • Cefuroxime
    • Ciprofloxacin
    Finland
Previous Page
1 … 230 231 232 233 234 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!